Universal Health Services (NYSE:UHS) Sees Promising Price Target from Barclays
- Barclays sets a new price target of $263 for NYSE:UHS, indicating a potential 22.88% increase.
- UHS reports a revenue of $4.5 billion for Q3 2025, a 13.4% year-over-year increase, surpassing estimates.
- The company's EPS for the same quarter was $5.69, exceeding consensus estimates and highlighting strong financial performance.
Universal Health Services (NYSE:UHS) is a prominent player in the healthcare sector, providing hospital and healthcare services across the United States. The company operates a network of acute care hospitals, behavioral health facilities, and ambulatory centers. UHS competes with other healthcare giants like HCA Healthcare and Tenet Healthcare, striving to deliver quality care and maintain financial growth.
On October 28, 2025, Barclays set a new price target of $263 for UHS, a significant increase from its current stock price of $214.03. This target suggests a potential 22.88% rise, reflecting confidence in UHS's future performance. The stock's recent price movement, with a 1.59% increase to $214.03, indicates positive investor sentiment.
UHS's strong financial results for the quarter ending September 2025 support Barclays' optimistic outlook. The company reported a revenue of $4.5 billion, a 13.4% increase from the previous year, surpassing the Zacks Consensus Estimate of $4.31 billion. This resulted in a positive surprise of 4.23%, showcasing UHS's ability to exceed market expectations.
The company's earnings per share (EPS) also impressed, reaching $5.69 compared to $3.71 in the same quarter last year. This EPS exceeded the consensus estimate of $4.66, delivering a substantial surprise of 22.1%. Such strong financial performance highlights UHS's capability to drive growth and profitability, reinforcing the positive outlook on its stock price.
UHS's market capitalization stands at approximately $13.62 billion, reflecting its significant presence in the healthcare industry. The stock's trading volume today is 921,195 shares, indicating active investor interest. With a 52-week high of $214.28 and a low of $152.33, UHS's stock performance demonstrates resilience and potential for further growth.
| Symbol | Price | %chg |
|---|---|---|
| SRAJ.JK | 11725 | 1.71 |
| MIKA.JK | 2630 | 0.76 |
| SILO.JK | 2090 | 1.91 |
| HEAL.JK | 1490 | -0.67 |
Universal Health Services, Inc. (NYSE:UHS) - A Strong Contender in the Healthcare Sector
- 30-day gain of 3.38% reflects strong investor confidence and positive market sentiment.
- Despite a 1.91% decline over the last 10 days, this dip might offer a buying opportunity for investors.
- Expected appreciation of 14.75% backed by UHS's strategic positioning and strong fundamentals.
Universal Health Services, Inc. (NYSE:UHS) is a prominent player in the healthcare sector, providing hospital and healthcare services across the United States. The company operates a network of acute care hospitals, behavioral health facilities, and ambulatory centers. UHS competes with other healthcare giants like HCA Healthcare and Tenet Healthcare, making its recent performance and growth potential noteworthy.
UHS has shown a 30-day gain of 3.38%, reflecting strong investor confidence and positive market sentiment. This gain is significant in the competitive healthcare industry, where market dynamics can be volatile. Despite a 1.91% decline over the last 10 days, this dip might offer a buying opportunity for investors anticipating a rebound.
The stock's growth potential is robust, with an expected appreciation of 14.75%. This potential is backed by UHS's strategic positioning and strong fundamentals in the healthcare sector. Investors looking for growth opportunities may find UHS's prospects appealing, given its solid market presence and operational efficiency.
UHS's financial health is underscored by a Piotroski Score of 8, indicating strong profitability and efficient operations. This score suggests that UHS is well-managed financially, which is crucial for sustaining growth and delivering shareholder value. The company's sound financial management is a key factor in its investment appeal.
Analysts have set a target price of $226.33 for UHS, highlighting a substantial upside from current levels. This target price reflects market confidence in UHS's ability to deliver value. Additionally, the recent touch of a local minimum suggests a potential support level, making it an attractive entry point for investors.
Universal Health Services, Inc. (NYSE: UHS) Quarterly Earnings Preview
- Earnings per Share (EPS) is expected to be $4.85, marking a 12.5% increase from the previous year.
- Projected revenue of $4.24 billion, an 8.2% year-over-year growth, driven by the Acute Care and Behavioral Health segments.
- Despite positive growth, a slight downward revision of 0.5% in the consensus EPS estimate over the past 30 days signals investor caution.
Universal Health Services, Inc. (NYSE:UHS) is a major player in the U.S. healthcare sector, operating a wide range of hospitals and healthcare facilities. The company is set to release its quarterly earnings on July 28, 2025. Analysts expect earnings per share (EPS) to be $4.85, a 12.5% increase from the previous year, with projected revenue of $4.24 billion.
The anticipated revenue growth of 8.2% year-over-year is largely attributed to the strong performance of UHS's Acute Care and Behavioral Health segments. These segments have seen increased admissions and demand, driving the company's financial performance. However, rising labor and supply costs could impact profit margins, potentially affecting UHS's ability to exceed earnings expectations.
Despite the positive outlook, there has been a slight downward revision of 0.5% in the consensus EPS estimate over the past 30 days. Such revisions are important as they often signal potential investor actions and can influence the short-term price performance of a stock. Investors will be keenly watching the earnings release for any surprises.
UHS's financial metrics provide insight into its market valuation. The company has a price-to-earnings (P/E) ratio of 8.44, indicating how the market values its earnings. Its price-to-sales ratio is 0.62, suggesting a relatively low market valuation compared to its revenue. The enterprise value to sales ratio is 0.93, reflecting its total valuation in relation to sales.
The company's financial health is further highlighted by its debt-to-equity ratio of 0.74, indicating a moderate level of debt compared to equity. Additionally, UHS has a current ratio of 1.32, suggesting it has sufficient liquidity to cover short-term liabilities. These metrics will be crucial for investors assessing UHS's financial stability and growth potential.
